Oncotelic Therapeutics (OTLC) Interest & Investment Income (2010 - 2020)
Oncotelic Therapeutics' Interest & Investment Income came in at $10.00 for Q1 2020, down 99.0% from $1,000 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Interest & Investment Income (2010 - 2020) Analysis & Trends
Over the trailing twelve months to Mar 31, 2020, Oncotelic Therapeutics reported Interest & Investment Income of $133.00, down 99.2% year-over-year; for FY2019, it was $123.00, down 99.2% from FY2018.
- Interest & Investment Income has declined in each of the last three years, with a five-year compound annual growth rate of -54.0% (FY2014 to FY2019).
- Going back by year, Interest & Investment Income was $16,000 in FY2018 (-54.3%), $35,000 in FY2017 (-67.0%), $106,000 in FY2016 (+292.6%) and $27,000 in FY2015 (+350.0%).
- The Q1 2020 figure represents the lowest quarterly Interest & Investment Income in data going back to Q3 2010.
- Year-over-year, Interest & Investment Income increased in 1 of the last six quarters, with an average decline of 36.2%.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2016 (growth of 833.3%), and the weakest in Q1 2020 (a decline of 99.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Oncotelic Therapeutics | 9.15 Mn | 7.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 10.00 |
| Jun 30, 2019 | 123.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | 2,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 12,000.00 |
| Mar 31, 2017 | 14,000.00 |
| Dec 31, 2016 | 22,000.00 |
| Sep 30, 2016 | 26,000.00 |
| Jun 30, 2016 | 29,000.00 |
| Mar 31, 2016 | 28,000.00 |
| Dec 31, 2015 | 12,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 3,000.00 |
| Dec 31, 2014 | 2,000.00 |
API Access
Oncotelic Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();